NCI Explores AI to Screen For and Treat Pancreatic Cancer
The institute sees the emerging technology supporting treatment for patients by better controlling tumor growth.
A new initiative at the National Cancer Institute aims to create capabilities for detecting pancreatic cancer early and improving treatments for patients with mutations.
A big challenge with pancreatic cancer resides in the KRAS gene. When mutated, the gene can cause normal cells to become cancerous. A new therapy involving KRAS inhibitors and genetic testing can help patients screen for this earlier.
Dr. Christine Alewine, the NIH Lasker Scholar in the Laboratory of Molecular Biology at NCI’s Center for Cancer Research, discussed this breakthrough, how new advancements can serve as an alternative treatment for chemotherapy and where AI can make an impact. Plus, she notes how other health issues such as diabetes also plays a role in screening for pancreatic cancer.
-
Dr. Christine Alewine NIH Lasker Scholar in the Laboratory of Molecular Biology, Center for Cancer Research NCI
-
NPS Launches First New NVIDIA AI Supercomputer in US Military
Naval Postgraduate School unveiled U.S. military's first NVIDIA DGX GB300 AI supercomputer to advance AI-enabled warfighting and research.
3m read -
Why Federal Tech Leaders Are Wearing Many Hats
Combining senior tech roles can streamline decision-making, but experts warn limited time and resources may hinder execution.
4m read -
NEA Leverages AI to Drive Software Development
NEA CIO Jim Tunnessen discusses AI-assisted software development, modernization, cybersecurity and responsible AI adoption across government.
7m watch -
VA Says GSA Partnership is Streamlining Procurement for IT
VA officials say a strengthened partnership with GSA is helping modernize procurement while supporting future investments in AI, IT and other technologies.
3m read
